Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
(NASDAQ: FULC) Delayed: 3.72 -0.04 (1.06%)
Previous Close $3.76    52 Week High
Open $3.78    52 Week Low
Day High $3.81    P/E N/A 
Day Low $3.70    EPS
Volume 572,862